Submitted by: Submitted by fatosber
Views: 186
Words: 1238
Pages: 5
Category: Business and Industry
Date Submitted: 10/20/2013 03:54 PM
Team Case Analysis
RU 486
Name(s): Abdullah Alshriden, Abdullah Almoqren, Fatos Berisha
|Situation analysis: |
|Roussel – Uclaf is a global pharmaceutical company based in France and owned by German chemical company Hoechst. RU is the |
|pharmaceutical market leader in France and has a strong presence worldwide with two thirds of all revenue originating from |
|international sales. |
|They are renowned world over for the importance they attach to Research and Development. |
|Roussel - Uclaf have synthesized a safe for use abortion drug (RU 486) that is causing controversy within societal groups. |
|The French government authorized the drug within the same legal limitations as surgical abortion (Abortion is Legal in France |
|before the 10th week of pregnancy). |
|Extensive clinical tests have confirmed the safety of the drug. RU and WHO carried out tests in France, England, and developing |
|countries as well. |
|Abortion with RU 486 as opposed to surgical abortion has several medical advantages. There is no need for anesthesia, it eliminates|
|the risk of uterus complications and it costs are lower. |
|RU faced internal and external pressure from its parent company, employees and society not to proceed with marketing RU 486 because|
|of their moral beliefs. This was especially true in France and the United States where sales were not expected to be high. On the |
|other hand...